LIMINAL BIOSCIENCES INC. Revaluation Surplus
LIMINAL BIOSCIENCES INC. had Revaluation Surplus of CAD 46.50 million as of 2023-06-30, per its 6-K filed 2023-08-08.
Discontinued › Notes
ifrs-full:RevaluationSurplus · last filed 2023-08-08
- 2023-06-30: Revaluation Surplus 46.50M CAD.
- 2022-12-31: Revaluation Surplus 45.97M CAD.
- 2022-06-30: Revaluation Surplus 45.27M CAD.
- 2021-12-31: Revaluation Surplus 44.11M CAD.
| Period end | Revaluation Surplus |
|---|---|
| 2023-06-30 | 46.50M CAD 6-K · filed 2023-08-08 |
| 2022-12-31 | 45.97M CAD 6-K · filed 2023-08-08 |
| 2022-06-30 | 45.27M CAD 6-K · filed 2022-08-10 |
| 2021-12-31 | 44.11M CAD 20-F · filed 2023-03-15 |
| 2021-06-30 | 41.72M CAD 6-K · filed 2021-08-16 |
| 2020-12-31 | 39.88M CAD 20-F · filed 2022-03-18 |
| 2020-06-30 | 38.53M CAD 6-K · filed 2020-08-10 |
| 2019-12-31 | 43.53M CAD 20-F · filed 2021-03-24 |
| 2018-12-31 | 21.92M CAD 20-F · filed 2020-03-20 |